Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Completed NCT07711275

Hypoglycemia Thresholds in Type 1 Diabetes

Conditions: Diabetes Mellitus, Type 1

Sex: All
Ages: 7 Years – 18 Years
Healthy volunteers: No
Phase: NA
Enrollment: 33
Sponsor: Marmara University

Location: Marmara University Istanbul

Summary

The aim of this study is to compare the impact of hypoglycaemia treatment initiated at a blood glucose threshold of 65 mg/dL versus the internationally recommended threshold of 70 mg/dL on 2-hour post-treatment blood glucose levels and the subsequent development of rebound hyperglycaemia in children with type 1 diabetes. The main questions it aims to answer are: Is there a statistically significant difference in 2-hour post-treatment blood glucose levels in children with type 1 diabetes when hypoglycaemia intervention is initiated at a threshold of 70 mg/dL compared to 65 mg/dL?" In children with type 1 diabetes, does the standard hypoglycaemia treatment initiated at the internationally recommended threshold of 70 mg/dL lead to the development of rebound hyperglycaemia (\

Eligibility Criteria

Inclusion Criteria: * A confirmed diagnosis of type 1 diabetes. * Absence of any concurrent chronic illnesses. * Absence of any physiological conditions precluding oral intake. * Absence of significant cognitive or developmental disorders that would impede capacity to participate in the study. * Aged between 7 and 18 years (as children under 7 years of age may experience difficulty consuming whole grain crackers). * Possession of a personal blood glucose monitor. * Absence of persistent hyperglycaemia. Exclusion Criteria: * Days characterised by unusually high levels of routine exercise or physical activity. * The requirement for a second dose of simple carbohydrates (sugar cubes) during a single hypoglycaemia intervention (as consuming two doses may induce hyperglycaemia following the snack). * Experiencing multiple hypoglycaemic episodes within the same day.

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT07711275). StuddyBuddy aggregates publicly available trial information.